"MDMA Will be a Prescribable Medicine in Two Years" | Interview with PETER GASSER, MD | ICPR 2022

"MDMA Will be a Prescribable Medicine in Two Years" | Interview with PETER GASSER, MD | ICPR 2022

PETER GASSER, MD is a Psychiatrist and Psychotherapist in Switzerland.
Recorded at the Interdisciplinary Conference on Psychedelic Research (ICPR) 2022, in Haarlem, The Netherlands.
https://www.icpr-conference.com/
https://drugreporter.net
Questions:
0:00 Intro
0:05 Please introduce yourself and your work!
0:54 What brought you into this field?
1:52 Why are therapists interested in psychedelics?
3:15 How do psychedelics compare to traditional psychiatric drugs?
4:25 Is it the substance that has the healing potential, or is it only the substance embedded in this therapeutic context, assisting psychotherapy?
5:53 What does psychedelic assisted therapy look like in the real world?
7:05 Do you have any exclusion criteria? People you definitely would not work with?
8:18 Can a psychedelic experience induce a psychotic episode in an otherwise healthy individual?
9:24 What kind of training professionals need to provide psychedelic therapy?
10:34 Do you think therapists need subjective experiences with psychedelic drugs?
11:33 This is a multi hour long session, and must be very exhausting for the therapist. What does it look like from your side?
13:11 Psychedelic therapy now is mostly available for the upper middle class. Do you think the costs can be reduced and made available for the wider public and more marginalised people?
14:24 You did the first human LSD study after the long ban. How do you feel about the current wave of new research?
15:34 How do you see the future of psychedelics will find their way to mainstream medical care?


Drugreporter (EN): https://www.drugreporter.net/ Facebook (HU): https://www.facebook.com/drogriporter/ Facebook (EN): https://www.facebook.com/drugreporter/ Instagram (HU): https://www.instagram.com/drogriporter/ Instagram (EN): https://www.instagram.com/rrfdrugreporter/ X.com (EN): https://x.com/RRFdrugreporter TikTok (EN): https://www.tiktok.com/@drugreporter_rrf/ Bluesky (EN): https://www.bsky.app/profile/drugreporter.bsky.social/ A Jogriporter Alapítvány: https://www.jogriporter.hu/ The Rights Reporter Foundation: https://www.rightsreporter.net/

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(123)

ROBERT JESSE | The value of community can help psychedelics move into mainstream culture

ROBERT JESSE | The value of community can help psychedelics move into mainstream culture

At ICPR 2024, we talked to Robert Jesse, from the Johns Hopkins University, about mystical experiences with psychedelics, their spiritual and cultural dimensions, and the value of community in support...

18 Sep 27min

LEONIE SCHNEIDER, BSC & IAN ROULLIER, MA | We need compassionate access to psychedelic treatment

LEONIE SCHNEIDER, BSC & IAN ROULLIER, MA | We need compassionate access to psychedelic treatment

At ICPR 2024, we talked to Leonie Schneider and Ian Roullier, co-founders and co-directors of the Psychedelic Participant Advocacy Network (PsyPAN) in the UK, about why patient voices matter in the de...

18 Sep 21min

Psychedelics: Saving Lives and Transforming Health Care – Interview with Tomáš Páleníček, MD, PhD

Psychedelics: Saving Lives and Transforming Health Care – Interview with Tomáš Páleníček, MD, PhD

Psychedelic research in the Czech Republic has a long and distinguished history. At ICPR 2026, we spoke with psychiatrist and neuroscientist Tomáš Páleníček about clinical research, altered states of ...

18 Sep 26min

WIM VAN DEN BRINK | Psychedelics help reduce compulsive thinking, such as craving in drug addiction

WIM VAN DEN BRINK | Psychedelics help reduce compulsive thinking, such as craving in drug addiction

At ICPR 2024, we talked to Wim van den Brink, MD, PhD, Professor of Psychiatry and Addiction at the Academic Medical Center, University of Amsterdam, about the potential of psychedelics to reduce comp...

31 Aug 29min

Psychedelics: The State of the Science in 2026 – Interview with Sandeep Nayak, MD

Psychedelics: The State of the Science in 2026 – Interview with Sandeep Nayak, MD

What actually makes psychedelic therapy work? Is it the drug, the therapeutic setting, or the human relationship between therapist and participant? At ICPR 2026, we spoke with psychiatrist and researc...

31 Aug 33min

NICOLAS LANGLITZ, MD, PHD: You have to find a space for these wild psychedelics in a rule governed world

NICOLAS LANGLITZ, MD, PHD: You have to find a space for these wild psychedelics in a rule governed world

At ICPR 2024, we talked to anthropologist and author Nicolas Langlitz about the current hype around psychedelics, their place in medicine and culture, and why he sees them as holding the promise of mo...

31 Aug 29min

Psychedelics and the Female experience – Interview with Grace Blest-Hopley, PhD

Psychedelics and the Female experience – Interview with Grace Blest-Hopley, PhD

Women make up more than half of the population, yet they remain significantly underrepresented in psychedelic research. At ICPR 2026, we spoke with neuroscientist Grace Blest-Hopley about the gender g...

31 Aug 31min

MARC B. AIXALÀ: Bad trips can transform into potentially positive outcomes

MARC B. AIXALÀ: Bad trips can transform into potentially positive outcomes

At ICPR 2024, we talked to psychologist and psychotherapist Marc B. Aixalà about how so-called “bad trips” can be reframed as difficult but potentially transformative experiences, and the importance o...

26 Mai 16min

Populært innen Politikk og nyheter

giver-og-gjengen-vg
aftenpodden
bt-dokumentar-2
popradet
aftenpodden-usa
forklart
stopp-verden
det-store-bildet
fotballpodden-2
nokon-ma-ga
dine-penger-pengeradet
rss-espen-lee-usensurert
rss-gukild-johaug
hanna-de-heldige
rss-ness
aftenbla-bla
rss-penger-polser-og-politikk
frokostshowet-pa-p5
e24-podden
saken